You are here:Home-Chemical Inhibitors & Agonists-Cytoskeleton/Cell Adhesion Molecules-Integrin-E7820
E7820

Chemical Structure : E7820

CAS No.: 289483-69-8

E7820 (E-7820)

Catalog No.: PC-20146Not For Human Use, Lab Use Only.

E7820 (E-7820) is a unique, oral sulfonamide derivative angiogenesis inhibitor, inhibits integrin α2 (ITGA2) mRNA expression and suppresses tube formation through the suppression of integrin alpha2.

Packing Price Stock Quantity
25 mg $268 In stock
100 mg $658 In stock
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

E7820 (E-7820) is a unique, oral sulfonamide derivative angiogenesis inhibitor, inhibits integrin α2 (ITGA2) mRNA expression and suppresses tube formation through the suppression of integrin alpha2.
E7820 inhibited in vitro proliferation and tube formation of human umbilical vascular endothelial cell (HUVEC).
E7820 decreased integrin alpha2, 3, 5, and beta1 in confluent culture of HUVEC, and integrin alpha2 was initially suppressed in mRNA level, followed by decrement of integrins alpha3, 5, and beta1.
E7820 reduced integrin alpha2 expression on a megakaryocytic cell line, Dami cells, induced by phorbol 12-myristate 13-acetate treatment.
Oral administration of E7820 significantly inhibited basic fibroblast growth factor-induced angiogenesis in Matrigel implants and human colon WiDr tumor-induced angiogenesis in a dorsal air sac model.
E7820 showed a broad-spectrum antitumor effect in mice through inhibition of angiogenesis.

Physicochemical Properties

M.Wt 336.37
Formula C17H12N4O2S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(3-Cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide

References

1. Yasuhiro Funahashi, et al. Cancer Res. 2002 Nov 1;62(21):6116-23.

2. Hülskamp MD, et al. BMC Cancer. 2021 May 18;21(1):571.

3. Semba T, et al. Clin Cancer Res. 2004 Feb 15;10(4):1430-8.

4. Mita M, et al. Clin Cancer Res. 2011 Jan 1;17(1):193-200.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: